Abacus Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403K Sell
1,112
-1,000
-47% -$342K 0.04% 188
2026
Q1
$743K Buy
2,112
+136
+7% +$48.5K 0.07% 142
2025
Q4
$647K Buy
+1,976
New +$627K 0.06% 169
2024
Q3
Sell
-660
Closed -$206K 94
2024
Q2
$206K Sell
660
-70
-10% -$20.6K 0.03% 81
2024
Q1
$208K Sell
730
-9
-1% -$2.63K 0.03% 83
2023
Q4
$213K Sell
739
-129
-15% -$35.1K 0.04% 74
2023
Q3
$233K Buy
+868
New +$217K 0.07% 65
2023
Q2
Sell
-1,127
Closed -$267K 87
2023
Q1
$267K Buy
+1,127
New +$277K 0.09% 71
2022
Q1
Sell
-2,771
Closed -$623K 90
2021
Q4
$623K Buy
2,771
+1,812
+189% +$382K 0.22% 43
2021
Q3
$204K Sell
959
-30
-3% -$6.91K 0.08% 113
2021
Q2
$241K Buy
989
+42
+4% +$10.3K 0.09% 96
2021
Q1
$236K Sell
947
-98
-9% -$23.4K 0.17% 91
2020
Q4
$240K Buy
+1,045
New +$241K 0.21% 75

Other funds holding AMGN

Abacus Wealth Partners's AMGN Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Amgen (AMGN) stake by 47% in Q2 2026, selling an estimated $342K and leaving 1,112 shares worth $403K. The position accounts for 0.04% of the portfolio, ranked #188.

Abacus Wealth Partners first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. The position peaked at $743K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Abacus Wealth Partners held 1,112 shares of Amgen worth $403K as of Q2 2026.
  • Abacus Wealth Partners sold 1,000 Amgen shares in Q2 2026, an estimated $342K.
  • Amgen made up 0.04% of Abacus Wealth Partners's portfolio in Q2 2026, its #188 holding.
  • Abacus Wealth Partners first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
  • Abacus Wealth Partners's Amgen position peaked at $743K in Q1 2026.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.